Community-acquired pneumonia: Symptoms and burden of illness at diagnosis among US adults aged 50 years and older

Patient

Volumn 6, Issue 2, 2013, Pages 125-134

  Wyrwich, Kathleen W ^a   Yu, Holly ^b   Sato, Reiko ^b   Strutton, David ^b   Powers, John H ^c  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b PFIZER INC   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COGNITION; COMMUNITY ACQUIRED PNEUMONIA; COUGHING; DIARRHEA; DYSPNEA; FAMILY; FATIGUE; FEMALE; FRIEND; HOSPITALIZATION; HUMAN; IMAGING; INFECTION RISK; LOW RISK POPULATION; MALE; MORBIDITY; MORTALITY; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; SEMI STRUCTURED INTERVIEW; SYMPTOM; THORAX PAIN; UNITED STATES; VOMITING; WEAKNESS; WEB BROWSER; WHEEZING;

ACTIVITIES OF DAILY LIVING; AGED; CAREGIVERS; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; COST OF ILLNESS; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PNEUMONIA; UNITED STATES;

EID: 84880120348     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.1007/s40271-013-0013-4     Document Type: Article

References (28)

1. Metlay JP, Fine MJ. Testing strategies in the initial management of patients with community-acquired pneumonia. Ann Intern Med. 2003;138(2):109-18.
2. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27-72.
3. Agency for Healthcare Research and Quality. Improving Treatment Decisions for Patients with Community-Acquired Pneumonia. [cited 2011 September 29]. http://www.ahrq.gov/clinic/pneumonia/pneumonria.htm.
4. Christensen KL, Holman RC, Steiner CA, et al. Infectious disease hospitalizations in the United States. Clin Infect Dis. 2009;49(7):1025-35.
5. Xu J, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: Final Data for 2007. National Vital Statistics Reports; vol 58 no 19. Hyattsville: National Center for Health Statistics; 2010.
6. American Lung Association. Lung Disease. [cited 2011 September 29]. http://www.lungusa.org/lung-disease/pneumonia/symptoms-diagnosis-and.html.
7. Metlay JP, Fine MJ, Schulz R, et al. Measuring symptomatic and functional recovery in patients with community-acquired pneumonia. J Gen Intern Med. 1997;12(7):423-30.
8. Metlay JP, Schulz R, Li YH, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med. 1997;157(13):1453-9.
9. Labarere J, Stone RA, Obrosky DS, et al. Comparison of outcomes for low-risk outpatients and inpatients with pneumonia: a propensity-adjusted analysis. Chest. 2007;131(2):480-8.
10. Fine MJ, Stone RA, Singer DE, et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med. 1999;159(9):970-80.
11. Brandenburg JA, Marrie TJ, Coley CM, et al. Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia. J Gen Intern Med. 2000;15(9):638-46.
12. El Solh A, Pineda L, Bouquin P, Mankowski C. Determinants of short and long term functional recovery after hospitalization for community-acquired pneumonia in the elderly: role of inflammatory markers. BMC Geriatr. 2006;6:12.
13. Marrie TJ, Lau CY, Wheeler SL, et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-acquired pneumonia intervention trial assessing levofloxacin. JAMA. 2000;283(6):749-55.
14. Carratala J, Fernandez-Sabe N, Ortega L, et al. Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients. Ann Intern Med. 2005;142(3):165-72.
15. El Moussaoui R, Opmeer BC, de Borgie CA, et al. Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia. Chest. 2006;130(4):1165-72.
16. Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity - establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1-eliciting concepts for a new PRO instrument. Value Health: J Int Soc Pharmacoecon Outcomes Res. 2011;14(8):967-77.
17. Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2-assessing respondent understanding. Value Health: J Int Soc Pharmacoecon Outcomes Res. 2011;14(8):978-88.
18. Zhanga L. Post-stratification and calibration - a synthesis. Am Stat. 2000;54(3):178-84.
19. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997;46(RR-8):1-24.
20. Centers for Disease Control and Prevention. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morbidity and mortality weekly report. 2010;59(34):1102-6.
21. Marrie TJ, Haldane EV, Faulkner RS, Durant H, Kwan C. Community-acquired pneumonia requiring hospitalization. Is it different in the elderly? J Am Geriatr Soc. 1985;33(10):671-80.
22. Roghmann MC, Warner J, Mackowiak PA. The relationship between age and fever magnitude. Am J Med Sci. 2001;322(2):68-70.
23. Loeb M. Pneumonia in older persons. Clin Infect Dis. 2003;37(10):1335-9.
24. Aujesky D, Auble TE, Yealy DM, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med. 2005;118(4):384-92.
25. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377-82.
26. Fernandez-Sabe N, Carratala J, Roson B, et al. Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine. 2003;82(3):159-69.
27. Muller B, Harbarth S, Stolz D, et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis. 2007;7:10.
28. Metlay JP, Atlas SJ, Borowsky LH, Singer DE. Time course of symptom resolution in patients with community-acquired pneumonia. Respir Med. 1998;92(9):1137-42.